Chemonics scored a 90 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, the company increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Chemonics forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Chemonics offers unconscious bias and microaggression training to its leadership. The company is committed to achieving net zero emissions by 2040. Chemonics supports DEI within its business practices, hosting a D&I Council, a D&I Office, and employing a Senior Director of DEI. "We aspire to embed DEI in all we do by focusing on three strategic areas: the workforce, the workplace, and our interactions with the industry and our stakeholders. We continually build organizational capacity to engage meaningfully across differences and foster DEI". The company’s CEO, Jamey Butcher, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. Chemonics launched an initiative called SCORE, which has pledged almost $10 million from 2020-2023 to "advance racial equality within Chemonics, our community, and the development sector”. For these reasons, Chemonics International receives a High Risk rating.